Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-004375)

Filing Details

Accession Number:: 0000899243-20-004375
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-12 19:03:08
Reporting Period:: 2020-02-10

Accepted Time:: 2020-02-12 19:03:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1743881	Bridgebio Pharma Inc.	BBIO	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1192591	J Charles Homcy	C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301	Chairman Of Pharmaceuticals	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-02-10	20,000	$36.00	1,342,291	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2019.